Skip to Main Content

Moderna Therapeutics, a biotech company valued at more than $7 billion, is plotting to raise $500 million in what would be the sector’s largest-ever initial public offering.

The company, based in Cambridge, Mass., filed with the Securities and Exchange Commission on Friday in the first step toward listing its shares on the Nasdaq.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

Comments are closed.